| 1 |
30699850 | CRMP2 mediates GSK3β actions in the striatum on regulating neuronal structure and mania-like behavior. | 2019 Feb 15 |
1 |
| 2 |
26909848 | Antipsychotic-like effects of a neurotensin receptor type 1 agonist. | 2016 May 15 |
1 |
| 3 |
25852508 | Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD. | 2015 |
6 |
| 4 |
27152166 | The physiological relevance of functional selectivity in dopamine signalling. | 2014 Jul |
1 |
| 5 |
23099259 | Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice. | 2013 Jan 5 |
4 |
| 6 |
23707483 | Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease. | 2013 Oct |
1 |
| 7 |
22434044 | Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice. | 2012 Jul |
9 |
| 8 |
22649795 | Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse. | 2012 May 16 |
5 |
| 9 |
20357757 | Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. | 2010 Jul |
1 |
| 10 |
14745448 | Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. | 2004 Feb |
1 |
| 11 |
15044694 | Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. | 2004 Apr 6 |
1 |